Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
Pw5DCma9sSL68j8s